Lv68
2580 积分 2024-11-28 加入
Surufatinib combined with sintilimab and IBI310 for the treatment of high‐grade advanced‐neuroendocrine neoplasms: A single arm, open‐label, single‐center, phase II study
20天前
已完结
Prognostic Significance of CTNNB1 Mutation in Recurrence of Sporadic Desmoid Tumors
5个月前
已完结
Desmoid tumors: who, when and how to treat?
5个月前
已完结
Lack of Prognostic Value of CTNNB1 Mutation Profile in Desmoid-Type Fibromatosis
5个月前
已完结
A cost analysis of sorafenib for desmoid tumors
5个月前
已关闭
Nirogacestat effective in desmoid tumours
5个月前
已完结
Active surveillance and emerging medical treatment options for desmoid: when and for whom?
5个月前
已完结
Multiple maxillofacial desmoid tumours: a case report
5个月前
已完结
Nirogacestat: First Approval
5个月前
已完结
Examining nirogacestat for adults with progressing desmoid tumors who require systemic treatment
5个月前
已完结
皖公网安备34019202002308
